CYP2D6 and chronic myelogenous leukemia, BCR-ABL1 positive: The polymorphic heterozygous variant allele (IM) in CYP2D6 was uncommon among Ph-ve CML patients when compared with the control group, suggesting that the (IM) allele could potentially have a protective effect against Ph-ve CML.